Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Keren Yizhak et al.|Cell|2018Cited by 2k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, David Liu et al.|Cell|2018Cited by 1.5k
Resistance to checkpoint blockade therapy through inactivation of antigen presentationMoshe Sade-Feldman, Nir Hacohen, Yunxin J. Jiao et al.|Nature Communications|2017Cited by 999
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Eytan Ruppin, Gao Zhang et al.|Nature Medicine|2018Cited by 813
Molecular Pathways of Colon Inflammation Induced by Cancer ImmunotherapyAdrienne Luoma, Kai W. Wucherpfennig, Shengbao Suo et al.|Cell|2020Cited by 478